TC-MCH 7C
中文名称 | TC-MCH 7C |
---|---|
中文同义词 | 化合物 T13101;TC-MCH 7C,黑色素浓缩激素受体1(MCH1R)拮抗剂 |
英文名称 | TC-MCH 7c |
英文同义词 | TC-MCH 7c;4-[(4-Fluorophenyl)methoxy]-1-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2(1H)-pyridinone;4-(4-Fluoro-benzyloxy)-1-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-1H-pyridin-2-one;TCMCH 7c,TC MCH 7c;2(1H)-Pyridinone, 4-[(4-fluorophenyl)methoxy]-1-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]- |
CAS号 | 864756-35-4 |
分子式 | C24H25FN2O3 |
分子量 | 408.47 |
EINECS号 | |
相关类别 | |
Mol文件 | 864756-35-4.mol |
结构式 |
TC-MCH 7C 性质
熔点 | 124-126 °C |
---|---|
沸点 | 606.3±55.0 °C(Predicted) |
密度 | 1.27±0.1 g/cm3(Predicted) |
储存条件 | Store at RT |
溶解度 | 1eq 中可溶解至 100 mM。 HCl 和 50 mM DMSO 溶液 |
形态 | 粉末 |
酸度系数(pKa) | 9.60±0.20(Predicted) |
IC50: 5.6 nM (hMCH
1
R)
Ki: 3.4 nM (hMCH
1
R) and 3.0 nM (mouse MCH
1
R)
TC-MCH 7c has an IC
50
of 9.7 μM for MCH
1
R in [Ca
2+
]i mobilization.
TC-MCH 7c has IC
50
s of 23 nM and 9.0 μM for FLIPR and hERG, respectively.
TC-MCH 7c (oral; 3-30 mg/kg; once-daily for 1.5 months) exhibits excellent body weight reduction in a dose-dependent manner in DIO mice model.
TC-MCH 7c (oral; 3-30 mg/kg) with 30 mg/kg has plasma concentrations of 5.1, 1.8, and 0.7 μM at 2, 15, and 24 hours, respectively.
Animal Model: | C57BL/6J DIO mice |
Dosage: | 3, 10 and 30 mg/kg |
Administration: | Oral; once-daily for 1.5 months |
Result: | Exhibited excellent body weight reduction in a dose-dependent manner. |
Animal Model: | Diet-induced obesity mice |
Dosage: | 3, 10 and 30 mg/kg (Pharmacokinetic Analysis) |
Administration: | Oral |
Result: | Plasma concentrations at 2, 15, and 24 hours were 5.1, 1.8, and 0.7 μM, respectively. |
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-107623 | TC-MCH 7C TC-MCH 7c | 864756-35-4 | 1mg | 1950元 |
2024/04/30 | HY-107623 | TC-MCH 7C TC-MCH 7c | 864756-35-4 | 5mg | 5850元 |